But Sox, bringing these drugs to market was never a priority for IPIX. Partnership is a priority, however. SP will not matter one iota to a BP. Our clinical trials are progressing as we all hoped they would. Maybe a little slower than some have anticipated, but progressing successfully none the less. The "market" doesn't even know that we exist currently. They will in short time, I believe. And I certainly think you're mistaken in your belief that we are not under attack by NSS'ers. That is the number 1 reason that our sp languishes at these levels currently, IMO. 4 kids and Alan have zeroed in on the problem and shine a bright light on it. I have not been convinced otherwise by you or F1ash on this matter. We will win in the end because our mgmt team knows WTF is going on and have taken steps to ensure our success, pending trial outcomes. The good guys win in this game sometimes too.